Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Jenburkt Pharmaceuticals had annual revenue of 1.69B INR with 11.24% growth. Jenburkt Pharmaceuticals had revenue of 446.32M in the quarter ending March 31, 2026, with 8.73% growth.

• Revenue: 1.69B
• Revenue Growth: +11.24%
• P/S Ratio: 2.92
• Revenue / Employee: 2.17M
• Employees: 779
• Market Cap: 4.92B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.69B	170.49M	11.24%
Mar 31, 2025	1.52B	97.25M	6.85%
Mar 31, 2024	1.42B	52.17M	3.82%
Mar 31, 2023	1.37B	127.69M	10.30%
Mar 31, 2022	1.24B	146.86M	13.44%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error